Wake Forest University spinout Renovo closed the round at $6.4m and will put the funding into further development of its brain injury treatment system.

Renovo Concepts, A US-based medical device developer leveraging research from Wake Forest University’s School of Medicine, has collected $6.4m of funding from undisclosed investors to close its series A round.
Founded in 2017, Renovo is developing and commercialising a mechanical tissue resuscitation (MTRTM) devices designed to treat traumatic brain injuries.
The company’s MTRTM treatments are derived from research conducted by Louis Argenta, the founder of the department of plastic and reconstructive surgery at Wake Forest University’s School of…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?